If you have a partial thickness rotator cuff tear, you may have been told that your main choices are physical therapy, waiting to see what happens, or rotator cuff surgery. But newer research may give you another option to discuss with your physician.

Long-term peer-reviewed research published in 2026 followed patients with partial thickness supraspinatus tears who received ultrasound-guided autologous bone marrow concentrate. The treatment targeted the injured tendon, the shoulder joint, and the subacromial space around the tendon.

After more than eight years of average follow-up, nearly 80% of patients had avoided rotator cuff surgery. Patients also experienced improvements in shoulder function, pain, and tear size on imaging.

These findings do not mean bone marrow concentrate can treat every rotator cuff tear. They do suggest that if you have the right type of tear and receive treatment at the right stage, regenerative medicine may deserve consideration before you assume surgery is inevitable.

Episode Video

Can You Treat a Partial Thickness Rotator Cuff Tear Without Surgery?

A partial thickness rotator cuff tear means part of your tendon is damaged, but the tear does not extend through the entire thickness of the tendon. One commonly injured tendon is the supraspinatus, which plays an important role in lifting and stabilizing your arm.

The key question is whether your partial tear can be treated before it progresses.

A 2026 study published in the Biologic Orthopedics Journal reported long-term outcomes for 24 patients with ultrasound-confirmed partial thickness supraspinatus tears. The patients were followed for at least seven years, with an average follow-up of 8.4 years.

Instead of treating only one painful spot, the procedure used image-guided bone marrow concentrate to address several parts of the shoulder during the same treatment session.

Bone Marrow Concentrate Treatment Targeted the Rotator Cuff Tendon, Shoulder Joint, and Bursa

The treatment used autologous bone marrow concentrate, meaning the material came from each patient's own body. About 120 milliliters of bone marrow aspirate was collected from the iliac crest of the pelvis and processed into approximately 12 milliliters of bone marrow concentrate. Using real-time ultrasound guidance, the concentrate was then delivered to three important areas of the shoulder.

Approximately six milliliters went into the glenohumeral joint. About one to three milliliters was delivered directly into the partial rotator cuff tear. The remaining three to five milliliters was placed into the subacromial space, where the bursa and tissues surrounding the tendon are located.

This approach treats your shoulder as a functional unit instead of focusing only on the visible tendon tear.

Nearly 80% of Patients Avoided Rotator Cuff Surgery Over More Than 8 Years

One of the most important findings involved rotator cuff surgery. Of the 24 patients followed in the study, 19 did not progress to rotator cuff surgery. That equals a surgical avoidance rate of approximately 79.2%.

Five patients eventually had surgery. Those patients tended to be older, have larger tears when treatment began, and have lower shoulder function scores at baseline.

This finding highlights an important point if you are considering treatment for a partial thickness rotator cuff tear: timing and patient selection may matter.

Shoulder Function Improved From 48 to 82 Out of 100

Avoiding surgery was not the only outcome measured. Among patients who did not undergo surgery, the Single Assessment Numeric Evaluation, or SANE score, increased from an average of 48 to 82 out of 100.

The SANE score is used to measure how you rate the function of an injured joint. A substantial increase indicates that patients felt their shoulders worked better over the long term.

Pain also improved. Average pain scores decreased from 4.6 to 2.1 on a 10-point scale, with improvement remaining durable through years of follow-up.

Partial Rotator Cuff Tears Became Smaller on Ultrasound

Perhaps one of the most interesting findings involved what happened to the tendon itself. At the beginning of the study, the average tear involved approximately 49% of the tendon thickness. At final follow-up, average tear size had decreased to approximately 28%. That represents a reduction of about 21 percentage points.

Complete structural healing, meaning that the tear was no longer visible on ultrasound, occurred in approximately 32% of patients. About 74% experienced either complete healing or measurable structural improvement.

This distinction matters because feeling better and demonstrating a structural change on imaging are not necessarily the same thing. In this study, researchers documented both clinical and imaging outcomes.

What Happens If You Simply Watch and Wait on a Partial Rotator Cuff Tear?

Understanding the study becomes more meaningful when you compare its findings with the known natural history of partial thickness rotator cuff tears.

An earlier study followed 40 patients with joint-side partial thickness rotator cuff tears for a little more than one year. Only four tears disappeared on repeat imaging, while another four became smaller. Meanwhile, 21 of the 40 tears became larger, and 11 progressed to full thickness rotator cuff tears.

In other words, only about 20% demonstrated structural improvement, while a large proportion enlarged or progressed.

That does not mean every untreated partial rotator cuff tear will become worse. It does show why simply assuming your tear will heal on its own may not be the best strategy.

Does Bone Marrow Concentrate Prove You Can Avoid Rotator Cuff Surgery?

Not quite. The eight-year study did not include a concurrent control group. Researchers compared their findings with previously published natural history data, and those older studies used different imaging methods. Because of these limitations, you cannot conclude that bone marrow concentrate alone caused every improvement.

However, the direction of the findings is important. Rather than showing progressive enlargement in most patients, the bone marrow concentrate study documented substantial surgical avoidance, reduced pain, improved function, and measurable reductions in tear size over long-term follow-up.

That makes this evidence worth discussing with a physician experienced in image-guided regenerative medicine.

Why Comprehensive Rotator Cuff Treatment May Matter

A rotator cuff tear does not exist in isolation. Your tendon works alongside the shoulder joint, bursa, surrounding muscles, cartilage, and underlying bone. Pain and loss of function may therefore involve more than the torn fibers seen on an ultrasound or MRI.

The published eight-year protocol addressed the rotator cuff tendon, glenohumeral joint, and subacromial space during the same session.

Some physicians are also exploring intraosseous bone marrow concentrate treatment, in which treatment is delivered into bone such as the humeral head when clinically appropriate.

Research involving intraosseous treatment in other joints has helped generate interest in the role of subchondral bone in joint pain and tissue health. However, intraosseous treatment of the humeral head was not part of the published eight-year rotator cuff study, so it should not be presented as an outcome proven by that particular research.

Who May Be a Candidate for Bone Marrow Concentrate for a Rotator Cuff Tear?

Your specific tear pattern matters. The 2026 study focused on adults with ultrasound-confirmed partial thickness supraspinatus tears. Patients with full thickness tears, previous shoulder surgery, diabetes, or corticosteroid injections in the affected shoulder during the previous three months were excluded.

In clinical practice, better candidates may include people with partial thickness rotator cuff tears or certain small to moderate full thickness tears without major tendon retraction.

Your tendon should generally have enough healthy tissue remaining, and imaging should not show advanced fatty atrophy of the rotator cuff muscles or major shoulder instability.

This is why an MRI or diagnostic ultrasound should be interpreted alongside your symptoms and physical examination rather than viewed as a stand-alone answer.

When Is a Rotator Cuff Tear Too Advanced for Regenerative Treatment?

Regenerative treatment is not appropriate for every shoulder injury. If you have a massive rotator cuff tear, significant tendon retraction, advanced fatty muscle atrophy, severe shoulder instability, or end-stage glenohumeral osteoarthritis, surgery may be a more appropriate option. Poorly controlled diabetes and recent corticosteroid exposure can also affect candidacy.

The important point is that your treatment options may change as your rotator cuff tear progresses. A partial tear with healthy surrounding tissue today may present a very different treatment opportunity than the same injury after years of progression, retraction, and muscle degeneration.

Why Timing Matters When Treating a Partial Thickness Rotator Cuff Tear

If you have already been diagnosed with a partial thickness rotator cuff tear, waiting indefinitely may carry consequences.

As a tear grows, it can progress toward a full thickness rotator cuff tear. The tendon can retract, while the associated muscle may develop fatty atrophy. Once these structural changes become advanced, biological treatment may become less appropriate and surgical repair may be necessary.

The patients who eventually needed surgery in the eight-year study tended to have factors such as larger tears, older age, and worse function at the beginning of treatment.

This does not mean you should rush into a procedure. It means you should understand the condition of your shoulder now so you can make an informed decision while multiple treatment options may still be available.

Final Thoughts

The new research offers encouraging long-term evidence for appropriately selected patients with partial thickness supraspinatus tears. Nearly 80% of study participants avoided rotator cuff surgery during more than eight years of follow-up. Shoulder function improved, pain decreased, and ultrasound imaging demonstrated measurable structural improvement in many patients.

At the same time, the research has limitations. It involved only 24 patients and lacked a concurrent control group. The findings should therefore be viewed as promising long-term evidence rather than proof that bone marrow concentrate will prevent surgery for everyone.

If you have shoulder pain and a partial thickness rotator cuff tear, your next question does not have to be, “When will I need surgery?” A more useful question may be, “Am I still a candidate for a nonsurgical treatment that matches my tear pattern, tissue quality, imaging findings, and overall health?”

Getting that answer sooner can help you understand whether physical therapy, image-guided regenerative medicine, surgery, or another approach makes the most sense for your shoulder.

Frequently Asked Questions

1. Can I heal a partial thickness rotator cuff tear without surgery?
   Some partial thickness rotator cuff tears can improve without surgery, depending on the size of your tear, tendon quality, symptoms, and overall shoulder health. Long-term research has also reported structural improvement in selected patients treated with ultrasound-guided bone marrow concentrate.

2. Can bone marrow concentrate help me avoid rotator cuff surgery?
   A 2026 study reported that approximately 79% of 24 patients with partial thickness supraspinatus tears avoided rotator cuff surgery during an average follow-up of 8.4 years. Your individual results can differ, and candidacy should be determined by a qualified physician.

3. How do I know if my rotator cuff tear is getting worse?
   Increasing pain, weakness, reduced shoulder function, or difficulty raising your arm may justify another evaluation, but symptoms alone cannot determine tear progression. Your physician may recommend an ultrasound or MRI to assess tear size, tendon retraction, muscle quality, and other structural changes.

4. Should I wait before treating my partial thickness rotator cuff tear?
   Waiting may be reasonable in some cases, but partial thickness tears can enlarge or progress over time. You should discuss your tear size, symptoms, tissue quality, and imaging findings with your physician to understand the risks and benefits of treatment versus continued observation.

5. Am I a good candidate for regenerative medicine for a rotator cuff tear?
   You may be a better candidate if you have a partial thickness tear, good remaining tendon tissue, limited retraction, and minimal fatty muscle atrophy. Massive tears, advanced retraction, severe arthritis, significant instability, and certain medical conditions may make other treatments more appropriate.

If you're ready to take control of your knee pain, click here to discover more about these five effective knee pain home treatments. With these simple steps, you can start your journey towards pain-free knees and a more active lifestyle.